These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26509904)

  • 21. Clear cell renal cell carcinoma: a comparative study of histological and chromosomal characteristics between primary tumors and their corresponding metastases.
    Dagher J; Kammerer-Jacquet SF; Dugay F; Beaumont M; Lespagnol A; Cornevin L; Verhoest G; Bensalah K; Rioux-Leclercq N; Belaud-Rotureau MA
    Virchows Arch; 2017 Jul; 471(1):107-115. PubMed ID: 28488172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment.
    Kouba EJ; Eble JN; Simper N; Grignon DJ; Wang M; Zhang S; Wang L; Martignoni G; Williamson SR; Brunelli M; Luchini C; Calió A; Cheng L
    Mod Pathol; 2016 Nov; 29(11):1347-1357. PubMed ID: 27469331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosomal abnormalities in renal cell carcinoma variants detected by Urovysion fluorescence in situ hybridization on paraffin-embedded tissue.
    Reid-Nicholson MD; Motiwala N; Drury SC; Peiper SC; Terris MK; Waller JL; Ramalingam P
    Ann Diagn Pathol; 2011 Feb; 15(1):37-45. PubMed ID: 21238914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.
    Ogawa O; Habuchi T; Kakehi Y; Koshiba M; Sugiyama T; Yoshida O
    Cancer Res; 1992 Apr; 52(7):1881-5. PubMed ID: 1348014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of NDUFB6 due to 9p24.1-p13.3 loss is implicated in metastatic clear cell renal cell carcinoma.
    Narimatsu T; Matsuura K; Nakada C; Tsukamoto Y; Hijiya N; Kai T; Inoue T; Uchida T; Nomura T; Sato F; Seto M; Takeuchi I; Mimata H; Moriyama M
    Cancer Med; 2015 Jan; 4(1):112-24. PubMed ID: 25315157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas.
    Schwerdtle RF; Winterpacht A; Störkel S; Brenner W; Hohenfellner R; Zabel B; Huber C; Decker HJ
    Cancer Res; 1997 Nov; 57(22):5009-12. PubMed ID: 9371493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of genomic alterations associated with metastasis and cancer specific survival in clear cell renal cell carcinoma.
    Sanjmyatav J; Junker K; Matthes S; Muehr M; Sava D; Sternal M; Wessendorf S; Kreuz M; Gajda M; Wunderlich H; Schwaenen C
    J Urol; 2011 Nov; 186(5):2078-83. PubMed ID: 21944119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization.
    Bissig H; Richter J; Desper R; Meier V; Schraml P; Schäffer AA; Sauter G; Mihatsch MJ; Moch H
    Am J Pathol; 1999 Jul; 155(1):267-74. PubMed ID: 10393858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis.
    Gunawan B; Huber W; Holtrup M; von Heydebreck A; Efferth T; Poustka A; Ringert RH; Jakse G; Füzesi L
    Cancer Res; 2001 Nov; 61(21):7731-8. PubMed ID: 11691785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic alterations in metastatic renal cell carcinoma detected by comparative genomic hybridization: correlation with clinical and histological data.
    Junker K; Moravek P; Podhola M; Weirich G; Hindermann W; Janitzky V; Schubert J
    Int J Oncol; 2000 Nov; 17(5):903-8. PubMed ID: 11029490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk prediction for metastasis of clear cell renal cell carcinoma using digital multiplex ligation-dependent probe amplification.
    Yoshikawa Y; Yamada Y; Emi M; Atanesyan L; Smout J; de Groot K; Savola S; Nakanishi-Shinkai Y; Kanematsu A; Nojima M; Ohmuraya M; Hashimoto-Tamaoki T; Yamamoto S
    Cancer Sci; 2022 Jan; 113(1):297-307. PubMed ID: 34687579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events.
    Gronwald J; Störkel S; Holtgreve-Grez H; Hadaczek P; Brinkschmidt C; Jauch A; Lubinski J; Cremer T
    Cancer Res; 1997 Feb; 57(3):481-7. PubMed ID: 9012478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preservation of truncal genomic alterations in clear cell and papillary renal cell carcinomas with sarcomatoid features: An intra- and intertumoral, multifocal fluorescence in situ hybridization analysis reveals limited genetic heterogeneity.
    Sanfrancesco JM; Eble JN; Grignon DJ; Wang M; Zhang S; Sundaram CP; Idrees MT; Pili R; Kouba E; Cheng L
    Mol Carcinog; 2017 Nov; 56(11):2527-2537. PubMed ID: 28667776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal diagnosis and molecular cytogenetic characterization of a de novo unbalanced reciprocal translocation of der(9)t(9;14)(p24.2;q32.11) associated with 9p terminal deletion and 14q distal duplication.
    Chen CP; Lin CJ; Chern SR; Wu PS; Chen YN; Chen SW; Lee CC; Chen LF; Yang CW; Wang W
    Taiwan J Obstet Gynecol; 2016 Aug; 55(4):596-601. PubMed ID: 27590390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.
    El-Mokadem I; Fitzpatrick J; Bondad J; Rauchhaus P; Cunningham J; Pratt N; Fleming S; Nabi G
    Br J Cancer; 2014 Sep; 111(7):1381-90. PubMed ID: 25137021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma.
    Brunelli M; Gobbo S; Cossu-Rocca P; Cheng L; Hes O; Delahunt B; Pea M; Bonetti F; Mina MM; Ficarra V; Chilosi M; Eble JN; Menestrina F; Martignoni G
    Mod Pathol; 2007 Mar; 20(3):303-9. PubMed ID: 17277768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.
    Turajlic S; Xu H; Litchfield K; Rowan A; Chambers T; Lopez JI; Nicol D; O'Brien T; Larkin J; Horswell S; Stares M; Au L; Jamal-Hanjani M; Challacombe B; Chandra A; Hazell S; Eichler-Jonsson C; Soultati A; Chowdhury S; Rudman S; Lynch J; Fernando A; Stamp G; Nye E; Jabbar F; Spain L; Lall S; Guarch R; Falzon M; Proctor I; Pickering L; Gore M; Watkins TBK; Ward S; Stewart A; DiNatale R; Becerra MF; Reznik E; Hsieh JJ; Richmond TA; Mayhew GF; Hill SM; McNally CD; Jones C; Rosenbaum H; Stanislaw S; Burgess DL; Alexander NR; Swanton C; ;
    Cell; 2018 Apr; 173(3):581-594.e12. PubMed ID: 29656895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients.
    Fernandes FG; Silveira HCS; Júnior JNA; da Silveira RA; Zucca LE; Cárcano FM; Sanches AON; Neder L; Scapulatempo-Neto C; Serrano SV; Jonasch E; Reis RM; Evangelista AF
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Genetic Alterations in Renal Cell Carcinomas With Tubulocystic Pattern: Tubulocystic Renal Cell Carcinoma, Tubulocystic Renal Cell Carcinoma With Heterogenous Component and Familial Leiomyomatosis-associated Renal Cell Carcinoma. Clinicopathologic and Molecular Genetic Analysis of 15 Cases.
    Ulamec M; Skenderi F; Zhou M; Krušlin B; Martínek P; Grossmann P; Peckova K; Alvarado-Cabrero I; Kalusova K; Kokoskova B; Rotterova P; Hora M; Daum O; Dubova M; Bauleth K; Slouka D; Sperga M; Davidson W; Rychly B; Perez Montiel D; Michal M; Hes O
    Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):521-30. PubMed ID: 26447894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.